Einstein, M. H., Baron, M., Levin, M. J., Chatterjee, A., Fox, B., Scholar, S., . . . Dubin, G. (2011). Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine: Follow-up from months 12–24 in a Phase III randomized study of healthy women aged 18–45 years. Landes Bioscience.
Style de citation ChicagoEinstein, Mark H., et al. Comparative Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine and HPV-6/11/16/18 Vaccine: Follow-up From Months 12–24 in a Phase III Randomized Study of Healthy Women Aged 18–45 Years. Landes Bioscience, 2011.
Style de citation MLAEinstein, Mark H., et al. Comparative Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine and HPV-6/11/16/18 Vaccine: Follow-up From Months 12–24 in a Phase III Randomized Study of Healthy Women Aged 18–45 Years. Landes Bioscience, 2011.